Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTZ-951 vs Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Receiving Maintenance Hemodialysis
NCT04027517Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jan 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enarodustat in anemia of chronic kidney disease (CKD-A), sponsored by JW Pharmaceutical Corporation. Started Jan 2019; status: completed.
02
Drugs
enarodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04027517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04027517.